跳到主要內容

臺灣博碩士論文加值系統

(216.73.216.35) 您好!臺灣時間:2025/12/18 02:45
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:戴國銧
研究生(外文):Tai, Kuo-Kuang
論文名稱:貿易代理業如何永續經營及面對的問題如何解決?
論文名稱(外文):How to Perform Sustainable Management and Solve the Problems It Faces – A Distributing Company
指導教授:朱博湧朱博湧引用關係
指導教授(外文):Chu, Po-Young
口試委員:吳世英鄧美貞朱博湧
口試委員(外文):Wu, Shih-YingTeng, Mei-JenChu, Po-Young
口試日期:2019-5-31
學位類別:碩士
校院名稱:國立交通大學
系所名稱:管理學院高階主管管理碩士學程
學門:商業及管理學門
學類:其他商業及管理學類
論文種類:學術論文
論文出版年:2019
畢業學年度:107
語文別:中文
論文頁數:74
中文關鍵詞:生醫產業IT 產業生醫代理貿易商
外文關鍵詞:Bio-Med IndustryIT IndustryBio-Med distributors
相關次數:
  • 被引用被引用:0
  • 點閱點閱:220
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:0
生技醫療產業日新月異,如今又加上AI、IOT、Big Data,更是一日千里。在全球的高 速成長中,台灣近幾年在國家生醫產業重視、鼓勵之下,亦有好的成果 – 以抗體及細 胞治療把以前認為是絕症的疾病,漸漸可以治療;在癌症早期的發現及治療成效上也非 常可觀;失智症的預防也因早期了解 tau 蛋白的沉積而有所進展。生醫產業確實是未來 台灣可以對外競爭的利器。如果再結合IT產業,必將會成為另一新的產業,也可讓台 灣成長至另一高峰。生醫代理貿易商和一般貿易商的性質是不一樣的,除了擁有基本的 進口知識外,更需要專業的加持,甚至售後服務滿足客戶要求也是必需具備的。由此可 見,要成為生醫貿易商是不容易的,加上現在產品競爭激烈,生存已不容易,更何況要 成為業界的翹楚。國外公司與公司間的併購對全心投入的代理貿易商傷害非常大,如果沒有事先預防措施,會如文中提到的,公司就會永久消失。障礙的建立,如執照、專利, 甚至備胎的考量對大一點的公司風險管理都必須好好設計規劃。CSB 和其它許多公司一 樣均認為因併購而代理權被原廠收回,這是這行業的宿命,是不能改變的事實。 但經 過交大 EMBA 教授們的經營策略課程指導下,才知道事情不竟然如此。老師經營策略 課程中也特別提到取捨(trade off) 甚為重要。種什麼因,得什麼果,因果關係必須特別 關注,CSB 公司的轉型,以其現有優勢逐漸擁有自己研發的產品及自己的品牌,增加至服務領域,又在創新要求下,CSB 雖因廠商間併購而失去大代理,致公司因此虧損,不 能按照原定計劃 IPO。但也因此了解自己目前不優的體質,必須體質做適度的調整以被 大眾肯定。如此業績的成長就不會處處受人擺佈,也不會有太大的波動,未來也可以真正預測每年業績的成長,IPO才有其真正意義及價值。這篇論文中已經把個人永續經營 經驗及問題解決的方法,淋漓盡致的完全敘述表達,創業著實不是一件容易的事,但要 在競爭中繼續成長又更是困難重重。相信個人創業經驗歷程及精華處,可供後來者參考。
Bio-Med Industry changes for the better day by day, now with AI, IOT Big Data joining, it advances much more at a tremendous pace. Viewing the high speedy growth globally, within recent years Taiwan Bio-Med Industry have grown rapidly with satisfactory results too under the government’s encouragement using antibodies and cell to gradually cure diseases which before taken as uncured. Also, it is effective for earlier detection and curing. Based on the earlier detection of tau-protein, there makes great process. Bio-Med Industry is surely a good weapon to compete with others around the world. If integrating with IT Industry, it will create another new industry, making Taiwan with growth to top. The feature between Bio-Med distributors and normal distributors is different. Besides the normal/basic import/export knowledge, there needs much more professional training and experience, even good after-service to meet with customers’ needs. It is indeed difficult to become a Bio-Med distributor. It is hard to survive under the hard competitions, not to say to become the leading position in the field. The merge between suppliers brings serious harm to the distributors. If having no advanced protection, it is, just as mentioned, easily finished/disappeared. The risk control is a must to big scaled company, such as license, patent application, stand-by products, etc. CSB as well as other companies all think it is a density and inevitable to distributors when distributorship is terminated due to suppliers merged. While, from the course of Managing Strategy given by EMBA professors of National Chiao Tung University, I learn things may not happen like this. Trade Off is quite important, you need to decide which to keep and which to give up (As you saw, so you will reap). CSB’s transformation, with its ready priority, self-developed products, own brand, service center, etc. will be a good innovation. CSB, although lost a lot and delayed the original plan for IPO due to distributorship terminated due to suppliers merged, still fortunately learn its own current constitution. It needs adjust wholly to be realized. Then IPO creates its value. Only with this the sales growth will be not controlled by others, and have big alternation. Accordingly, it can estimate its annual business growth, and conduct IPO with its real meaning and value. Business establishing is not an easy thing, but, to manage continuously is much more difficult in competition. This essay well expresses personal experience of many years in business establishing and mainly - “How a distributing company to perform sustainable management and solve the problems it faces”. Believe it is a worthwhile reference to the new comings.
摘要....... i
Abstract...... ii
表目錄 ... vi
圖目錄 ............ vii
第一章 緒論......1
1.1 研究背景與動機......1
1.2 研究⽬的......1
1.3 研究⽅法概述 ...................1
1.3.1 研究⽅法.............1
1.3.2 資料搜集..........1
1.3.3 論⽂架構.............2
第二章 產業概況與文獻探討..........3
2.1 產業的介紹 .........3
2.2 全球的狀況 ........5
2.2.1 ⽣醫儀器與試劑代理業務市場現況...7
2.2.2 委託研究服務市場現況....8
2.2.3 個⼈化醫療市場現況.......9
2.3 未來台灣的⽣技產業變化、轉型與創新...14
第三章 研究方法 - 個案研究法.......22
3.1 CSB 公司的沿⾰與創新 .......22
3.1.1 本⾝是學 Biology..........22
3.1.2 服兵役時,⾝為化驗官...23
3.1.3 第⼀份⼯作當 sales →合伙 .....24
v
3.2 探討 CSB 公司⼩(⼀般)貿易時期營運策略與成效分析...25
3.3 探討 CSB 公司⼤ (動物影像與精準醫療)貿易時期營運策略...27
第四章 研究成果討論 ........55
4.1 經營公司遭遇的問題.....55
4.1.1 產品遭遇的問題.....55
4.1.2 ⼈員遭遇的問題............57
4.2 解決經營公司遭遇的問題......59
4.2.1 解決產品問題的⽅法....59
4.2.2 解決⼈員問題的⽅法.......61
4.3 未來成⾧和⽣存的挑戰............61
第五章 結論與建議.....................70
參考文獻 ...................73
附錄一:公司經營策略圖..........74
1. Luthra, Rajyalakshmi, et al. "Next-generation sequencing in clinical molecular diagnostics of cancer: advantages and challenges." Cancers 7.4 (2015): 2023-2036.
2. Coumans, Frank AW, Sabine Siesling, and Leon WMM Terstappen. "Detection of cancer before distant metastasis." BMC cancer 13.1 (2013): 283.
3. SWOT 分析模型 (https://wiki.mbalib.com/zh-tw/SWOT 分析模型)
4. 五力分析模型 (https://zh.wikipedia.org/wiki/wiki/五力分析)
5. 九宮圖分析法 (https://wiki.mbalib.com/zh-tw/九宫图分析法)
6. Lundy, David J., et al. "Inducing a Transient Increase in Blood–Brain Barrier Permeability for Improved Liposomal Drug Therapy of Glioblastoma Multiforme." ACS nano 13.1 (2018): 97-113.
7. Michael E. Porter., On Competition. Harvard Business Press, 2008.
8. 吳忠勳等人,2018 生技產業白皮書,經濟部工業局,2018 年 7 月。
9. 2019 生技醫療產業展望,勤業眾信,2019 年。
10. Frost & Sullivan: A Growth Strategy Consulting & Research Firm
連結至畢業學校之論文網頁點我開啟連結
註: 此連結為研究生畢業學校所提供,不一定有電子全文可供下載,若連結有誤,請點選上方之〝勘誤回報〞功能,我們會盡快修正,謝謝!
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top